Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus

Short- and Long-term Outcomes of De Novo Liver Transplant Patients Treated With Once-Daily Prolonged-Release Tacrolimus

Background. Tacrolimus is the key immunosuppressive drug for liver transplantation. Once-daily prolonged-release tacrolimus (TAC-PR) exhibits good drug adherence but has difficulty controlling the trough level in the early phase of liver transplantation. The aim of this study was to compare the feas...

Full description

Bibliographic Details
Main Authors: Yuichiro Okumura, MD, Takehiro Noda, MD, PhD, Hidetoshi Eguchi, MD, PhD, Yoshifumi Iwagami, MD, PhD, Daisaku Yamada, MD, PhD, Tadafumi Asaoka, MD, PhD, Hiroshi Wada, MD, PhD, Koichi Kawamoto, MD, PhD, Kunihito Gotoh, MD, PhD, Yutaka Takeda, MD, PhD, Masahiro Tanemura, MD, PhD, Shigeru Marubashi, MD, PhD, Koji Umeshita, MD, PhD, Yuichiro Doki, MD, PhD, Masaki Mori, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2017-09-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000722

Internet

http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000000722

Similar Items